Perform Rx Integrative Health in Tampa, Florida, lists bioidentical hormone replacement among its services, placing the business within a health care category attracting substantial global spending. For people searching for Tampa hormone replacement under the PerformRX name, the business presents a local example of a broader commercial question: how much can worldwide market forecasts actually tell patients and businesses about services in their own city?

A Tampa Business Built Around Hormones and Performance Medicine

Established approximately in 2026, Perform Rx Integrative Health describes its focus as “Precision Hormone & Performance Medicine for People Who Expect More.” Its listed services are Bioidentical Hormones (BHRT), Blood Work & Lab Services, Medically Guided Peptides, and Food Sensitivity Testing. That description establishes the business’s stated positioning and the categories it offers. It does not, on its own, establish patient outcomes, the number of people receiving treatment, or the relative importance of each service to the business. Those distinctions matter when assessing a health care company whose public identity combines a particular treatment category with the broader language of performance medicine.

The business identifies its location as Tampa, FL, and publishes a telephone number, (813) 566-0695, and an email address, info@performrxclinic.com. Its available business information supports a straightforward account of its identity and service menu, rather than a detailed operating history. The approximate establishment date should likewise be understood as approximate, not as a documented opening day. For a regional business audience, the concrete story is the presence of a Tampa company organizing its offering around hormones, laboratory services, medically guided peptides and food sensitivity testing. Claims about its market share, expansion plans or commercial results would require additional evidence not supplied by those basic facts.

Global Hormone Forecasts Leave Tampa Demand Unmeasured

Grand View Research estimates the global hormone replacement therapy market at $26.9 billion in 2026 and projects compound annual growth of 5.6% during 2026–2033, according to the market context supplied for this article. The same source reports that menopause accounted for 45.0% of global market revenue in 2025. These figures describe a worldwide market, not Tampa, and the forecast is a projection rather than an observed result for the full period. No verified Tampa-specific market size or growth rate was available for this article. Consequently, the global estimate cannot establish the scale of local spending, the pace of growth among Tampa providers, or revenue attributable to Perform Rx Integrative Health. Nor does the worldwide menopause share establish the patient mix of this particular business. A local economic assessment would need separately defined geographic and industry data; the U.S. Census Bureau’s business and economy resources provide an authoritative starting point for that broader research, but are not the source of the hormone-market estimates cited above.

The distinction is especially important for a specialized search such as “tampa hormone replacement PerformRX.” Search language connects a place, a treatment category and a business name; it does not measure how many people seek treatment or how much they spend. A defensible Tampa business analysis would separate population characteristics, employment conditions, provider activity and actual treatment demand rather than treating them as interchangeable. The U.S. Bureau of Labor Statistics’ employment and wage resources offer a primary-source foundation for examining labor conditions, although no employment statistic is asserted here and those resources do not substantiate the global hormone forecast. The business implication is therefore limited but useful: Perform Rx operates in a category with a substantial estimated worldwide market, while its local commercial opportunity remains unquantified in the available evidence. Neither the forecast growth rate nor the menopause revenue share should be carried over into a Tampa sales projection. Doing so would substitute a global category estimate for evidence about a particular city and company.

BHRT Sits Alongside Labs, Peptides and Food Sensitivity Testing

Perform Rx Integrative Health’s service list combines Bioidentical Hormones (BHRT) with Blood Work & Lab Services, Medically Guided Peptides, and Food Sensitivity Testing. Its stated description places those offerings within precision hormone and performance medicine. These are the specific service categories identified in the available business information. The listing does not specify particular hormone products, laboratory panels, peptide products or food sensitivity testing methods. It also does not supply prices, treatment schedules or eligibility criteria. Accordingly, the service menu can be reported as a description of the business’s offering without turning it into a claim about a particular treatment pathway. The available facts establish what categories the Tampa business lists, not what any individual patient would receive or what results that person could expect.

For Tampa’s business readership, Perform Rx Integrative Health illustrates the importance of keeping a company’s stated offering separate from the market narrative surrounding it. The documented local facts are its identity, approximate establishment year, Tampa location, contact information and four listed service categories. The global figures provide context, but leave the central local questions—market size, demand and business performance—unanswered. That is a narrower conclusion than a growth story built from worldwide projections, but it is also a more supportable one. Information about the business and its listed offerings is available at performrxclinic.com.

Further reading from The Capital Front: Dental NV’s Sterling Dental Practice Puts Access in Focus and Weight And Wellbeing Puts Skin Tightening Within a Broader Body-Care Offering.